Investing4 天
FDA approves Ozempic for kidney disease treatment in diabetes patients
The trial revealed that Ozempic® 1 mg significantly lowered the relative risk of worsening kidney disease, kidney failure, and cardiovascular death by 24% compared to a placebo, in addition to ...
Managed Healthcare Executive5 天
FDA Approves Ozempic to Reduce Kidney Disease in Type 2 Diabetes
Th FDA approval is based on results from the FLOW phase 3b kidney outcomes trial investigating the effects of once-weekly Ozempic 1 mg injection on major kidney and cardiovascular outcomes ... Ozempic ...
The New York Times5 天
F.D.A. Approves Ozempic to Treat Kidney Disease
By Dani Blum The Food and Drug Administration on Tuesday approved Ozempic to reduce the risk of serious complications in people who have both Type 2 diabetes and chronic kidney disease.
STAT4 天
Ozempic approved for chronic kidney disease patients
Novo Nordisk’s blockbuster diabetes drug Ozempic was approved by the FDA for patients with type 2 diabetes and chronic kidney disease. The drug was specifically cleared to reduce the risk of ...
Investing4 天
FDA approves Ozempic for kidney disease treatment in diabetes patients
The FDA's approval is based on the results of the FLOW phase 3b kidney outcomes trial. The trial revealed that Ozempic® 1 mg significantly lowered the relative risk of worsening kidney disease, kidney ...
英为财情4 天
FDA批准Ozempic用于治疗糖尿病患者的肾病
Investing.com -- 美国食品和药物管理局（FDA）已批准扩大使用诺和诺德制药公司开发的Ozempic®（semaglutide）注射剂。该药物现在获准用于降低成年2型糖尿病和慢性肾病（CKD）患者的肾病进展、肾衰竭和心血管死亡风险。这一扩大授权是在Ozempic现有用途的基础上，即 ...